Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to 0.77%.

  • Fortress Biotech's Return on Capital Employed rose 8400.0% to 0.77% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.77%, marking a year-over-year increase of 8400.0%. This contributed to the annual value of 1.31% for FY2024, which is 3300.0% down from last year.
  • Fortress Biotech's Return on Capital Employed amounted to 0.77% in Q3 2025, which was up 8400.0% from 0.94% recorded in Q2 2025.
  • Fortress Biotech's Return on Capital Employed's 5-year high stood at 0.33% during Q1 2021, with a 5-year trough of 2.6% in Q3 2023.
  • In the last 5 years, Fortress Biotech's Return on Capital Employed had a median value of 1.1% in 2025 and averaged 1.18%.
  • In the last 5 years, Fortress Biotech's Return on Capital Employed tumbled by -17100bps in 2023 and then surged by 10600bps in 2024.
  • Fortress Biotech's Return on Capital Employed (Quarter) stood at 0.61% in 2021, then tumbled by -83bps to 1.12% in 2022, then tumbled by -71bps to 1.92% in 2023, then rose by 11bps to 1.72% in 2024, then skyrocketed by 55bps to 0.77% in 2025.
  • Its Return on Capital Employed was 0.77% in Q3 2025, compared to 0.94% in Q2 2025 and 1.1% in Q1 2025.